Biobeat USA Inc.
$11.6K 85 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Greiner Bio-One North America, Inc.
Greiner Bio-One North America, Inc. reported $11,564.97 across General Payments, Research, and Ownership to 33 physicians and teaching hospitals across 33 transactions.
- $11.6K Below-median payer
- All-tracks total
- 33 Below-median volume
- Transactions
- 33 Below-median reach
- Recipients
- #1622
- of 1,925 companies
Greiner Bio-One North America, Inc. reported $11,564.97 across all CMS Open Payments tracks (General + Research + Ownership) to 33 physicians and teaching hospitals in Program Year 2024 - ranking #1622 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $11,564.97, averaging $350.45 per recipient.
Greiner Bio-One North America, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
20/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer greiner-bio-one-north-america-inc Greiner Bio-One North America, Inc.
$11.6K · #1622/1,925 · 0.0% industry · PY2024
- TOT $11.6K
- RANK #1622
- SHARE 0.0%
- TXN 33
- RCP 33
- CAT 4
- GEN $11.6K
- TOP1 21.7%
- PY 2024
Volume peers
Nearest volume peer: Biobeat USA Inc. ($11.6K)
Greiner Bio-One North America, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Greiner Bio-One North America, Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Greiner Bio-One North America, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
"Travel and Lodging" leads the 4-category general-payment breakdown below at $6.5K (55.9% of General Payments, 15 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Travel and Lodging" leads Greiner Bio-One North America, Inc.'s 4-category general-payment breakdown at $6.5K, 55.9% of the reported total.
Greiner Bio-One North America, Inc. reports 4 general-payment categories - the top three are Travel and Lodging (55.9%), Food and Beverage (39.0%), and Entertainment (3.0%). The remaining 1 category make up 2.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Greiner Bio-One North America, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Travel and Lodging | $6.5K | 15 | 55.9% |
| Food and Beverage | $4.5K | 6 | 39.0% |
| Entertainment | $349.50 | 5 | 3.0% |
| Gift | $235.20 | 7 | 2.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $10,455.93 (90.4%) of $11,564.97 in this company's General Payments records across 6 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Greiner Bio-One North America, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Uh Cleveland Medical Center
$2,507.67 across 7 reported transactions
- 2
Ut Md Anderson Cancer Center
$2,111.14 across 5 reported transactions
- 3
Riverside Methodist Hospital
$2,053.36 across 6 reported transactions
- 4
Childrens Hospital
$1,916.28 across 5 reported transactions
- 5
Geisinger Medical Center
$1,867.48 across 6 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Greiner Bio-One North America, Inc. ranks #1622 of 1,925 by total payments (bottom 16% by spend) but is notably more concentrated than that alone would suggest -- #803 of 1,838 by HHI (top 44% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Cerus Corporation : $405.7K total payments, HHI 1771
- Brixton Biosciences, Inc. : $36.4K total payments, HHI 1756
- Sysmex America, Inc. : $54.4K total payments, HHI 1755
- bluebird bio, Inc. : $208.3K total payments, HHI 1750
- Pfizer International LLC : $197.5K total payments, HHI 1747
- NextStep Arthropedix, LLC : $125.7K total payments, HHI 1747
- Greiner Bio-One North America, Inc. (this company) : $11.6K total payments, HHI 1746
- CashFlow Solutions, LLC : $89.2K total payments, HHI 1745
- Acumed LLC : $3.4M total payments, HHI 1742
- Thermo Fisher Scientific Asheville LLC : $2.2K total payments, HHI 1739
- Albireo Pharma, Inc. : $317.2K total payments, HHI 1739
- Puma Biotechnology, Inc. : $396.8K total payments, HHI 1733
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Greiner Bio-One North America, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Greiner Bio-One North America, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Greiner Bio-One North America, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
EnableCV Inc.
$11.6K 73 recipients
Compare payment profiles
Biolase MG LLC
$11.5K 13 recipients
Compare payment profiles
Xenco Medical LLC
$11.5K 5 recipients
Compare payment profiles
Hoya Surgical Optics, Inc
$11.7K 5 recipients
Compare payment profiles
Maxx Health Inc
$11.5K 27 recipients
Compare payment profiles
Put this to use
Greiner Bio-One North America, Inc. ranks #1622 of 1,925 by all-tracks total payments, led by "Travel and Lodging".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Travel and Lodging" spend across every manufacturer, not just Greiner Bio-One North America, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.